ArticleFrontiers in endocrinology2026
Lymphocyte-to-high-density lipoprotein ratio is negatively associated with diabetic macular edema in type 2 diabetic patients.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between peripheral blood biomarkers and diabetic macular edema.Acta diabetologica · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Systemic immune-inflammatory imbalance plays a potential role in the development of diabetic macular edema (DME). The lymphocyte-to-high-density lipoprotein ratio (LHR) can reflect the systemic immune-inflammatory status. This study aimed to explore the relationship between LHR and DME. Methods: This retrospective study enrolled 423 patients with diabetic retinopathy admitted to the same hospital between January 2022 and December 2024. Patients were categorized into DME (n = 163) and non-DME groups (n = 260) based on optical coherence tomography. Clinical and laboratory information was gathered, and LHR was calculated. Logistic regression models were conducted to explore the association between LHR and DME. Quartile grouping, quartile-based trend test, and subgroup analyses were used to verify the pattern of association. Restricted cubic splines (RCS) were used to assess nonlinear relationships. Sensitivity analysis was also conducted. Results: The DME group exhibited a significantly lower LHR level than in the non-DME group [1.55 (1.19, 2.04) vs. 1.94 (1.38, 2.47), P < 0.001]. Further adjusted regression models revealed that reduced LHR independently correlated with DME (aOR = 0.714, 95% CI: 0.541-0.942, P = 0.017). Quartile analysis demonstrated that the DME incidence in the Q1 group (LHR ≤ 1.32) was 48.1%, markedly higher than 27.6% in the Q4 group (LHR ≥ 2.40) (P = 0.002). RCS analysis verified a negative linear correlation between LHR and the odds of DME (P overall = 0.039, P nonlinear = 0.178). Sensitivity analysis supported the association (aOR = 0.698, 95% CI: 0.511-0.952, P = 0.023). Conclusion: Low LHR is independently associated with the presence of DME.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.